Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 4/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 4/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4902485 | 0.93 | TP53 (0.40) | TP53NPC1RAB9AALDH1A1TSHR | |
| SCHEMBL4900904 | 0.91 | NR1I2 (0.36) | TP53NPC1RAB9AALDH1A1TSHR | |
| SCHEMBL4902470 | 0.90 | TP53 (0.43) | TP53NPC1POLBRAB9AALDH1A1 | |
| SCHEMBL4906743 | 0.89 | ALDH1A1 (0.44) | TP53NPC1POLBRAB9AALDH1A1 | |
| SCHEMBL4898066 | 0.87 | ALDH1A1 (0.39) | TP53POLBALDH1A1TSHRMAPT | |
| SCHEMBL4897618 | 0.87 | TP53 (0.42) | TP53NPC1POLBRAB9AALDH1A1 | |
| SCHEMBL4899693 | 0.84 | TP53 (0.40) | TP53NPC1RAB9AALDH1A1TSHR | |
| SCHEMBL4904959 | 0.84 | MAPT (0.39) | TP53NPC1RAB9AALDH1A1TSHR | |
| SCHEMBL4904147 | 0.82 | ALDH1A1 (0.45) | TP53NPC1RAB9AALDH1A1TSHR | |
| SCHEMBL4902584 | 0.82 | MAPT (0.43) | TP53NPC1RAB9AALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080090829-A1 | SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS | PFIZER INC. | 2008-04-17 | — | — | US | disclosed |
| US-20060229363-A1 | Substituted Heteroaryl- and Phenylsulfamoyl Compounds | HAMANAKA ERNEST S | 2006-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060229363-A1 | Substituted Heteroaryl- and Phenylsulfamoyl Compounds | PPARA, PPARG, PPARD | TP53 3260/4885NPC1 50/4885POLB 1488/4885 |
| US-20080090829-A1 | SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS | PPARA, PPARG, PPARD | TP53 3421/4885NPC1 59/4885POLB 1807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.